Jan 10, 2019 - Zacks Market Edge Highlights: Tilray, Constellation Brands, Altria and GW Pharmaceuticals
Jan 03, 2019 - Given the stock market turbulence and specter of slower economic growth this year, investing in sin stocks seems prudent. The products or services in this space are relatively inelastic, and business is recession-proof.
Jan 02, 2019 - I recommend investing in medical marijuana specialty companies actually producing products of necessity especially GW Pharmaceuticals plc. Share price, fundamentals and financial technicals are all ri
Dec 18, 2018 - Epidiolex marketing and sales for childhood epilepsies now in full swing.Consensus sales forecasts for epidiolex and the promising pipeline suggest company may be undervalued.Off-label potential and o
Nov 27, 2018 - GWPH earnings call for the period ending September 30, 2018.
Nov 27, 2018 - GW Pharmaceuticals PLC (NASDAQ:GWPH) Q4 2018 Results Conference Call November 27, 2018 04:30 PM ET Executives Steve Schultz - Vice President of Investor Relations Justin Gover - Chief Executive Office
Nov 27, 2018 - Gainers: NTNX +8.4%. CRM +7.5%. TOWR +5.1%. GFI +4.7%. JILL +4.4%.Losers: ASNS -4.4%. GNL -4.3%. GWPH -4.0%.JAX -3.5%. SIGA -3.3%.
Nov 27, 2018 - Companies In The News Are:
Nov 26, 2018 - Biopharmaceutical company GW Pharma (GWPH 131.21, +7.16) advances about 5.8% on Monday after this mo
Nov 23, 2018 - On GW Pharmaceuticals' (GWPH) fourth-quarter conference call, investor focus will be on the company's launch and commercialization plans for its newly approved anti-epileptic drug Epidiolex.